Real-Time Reverse Transcription Polymerase Chain Reaction (PCR)/DNA Probe Hybridization
Provides qualitative detection of Zika virus RNA from urine collected during the acute phase of infection.
This test is intended for the evaluation of pregnant women and symptomatic nonpregnant individuals with potential exposure to Zika virus.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
6 - 10 days
Collect random urine in a sterile container and refrigerate.
Due to similar clinical presentations, testing for RNA or IgM-class antibodies to dengue and chikungunya viruses, concurrently with Zika virus testing, is strongly recommended. For the most up-to-date Zika epidemiology and testing recommendations, visit www.cdc.gov/zika/. Test sent to Mayo Medical Laboratories.